Source: Virtual Congress 2021 – COVID - 19 risk predictions



Rating:

Share or cite this content

Citations should be made in the following way:
R. Méndez (Valencia, Spain), P. González-Jiménez (Valencia, Spain), A. Latorre (Valencia, Spain), L. Serrano (Barakaldo, Spain), L. Ruiz (Barakaldo, Spain), R. Zalacaín (Barakaldo, Spain), P. España (Galdakao, Spain), A. Uranga (Galdakao, Spain), C. Cillóniz (Barcelona, Spain), A. Torres (Barcelona, Spain), R. Menéndez (Valencia, Spain). Early profiling of low-risk SARS-CoV-2 pneumonia for ward allocation. 3659

Member's Comments

No comment yet.

Related content which might interest you: Inter-hospital variation in resource utilization of diagnostic and follow-up biomarkers in adult community-acquired pneumonia Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Implementation of ERS guidelines for the management of adult community-acquired pneumonia in a primary care hospital Source: Eur Respir J 2001; 18: Suppl. 33, 503s Year: 2001 Molecular methods in evaluation of link between ventilator-associated pneumonia and patient's endogenous flora in paediatric intensive care unit Source: Eur Respir J 2001; 18: Suppl. 33, 457s Year: 2001 Use of a specific risk prediction rule for the hospital management of patients with community-acquired pneumonia Source: Eur Respir J 2003; 22: Suppl. 45, 546s Year: 2003 Intensive care unit acquired pneumonia with or without etiologic diagnosis: A comparison of outcomes Source: Annual Congress 2012 - Infections and sepsis in the ICU Year: 2012 A prediction rule to identify allocation of inpatient care in community-acquired pneumonia Source: Eur Respir J 2003; 21: 695-701 Year: 2003 Risk factors analysis influenced occurrence of ventilator-associated pneumonia in surgical intensive care unit Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Validation of treatment failure criteria of nosocomial pneumonia in ICU Source: Annual Congress 2011 - Intensive care outcome Year: 2011 Cost minimization for community-acquired pneumonia management in Belarussian hospital from implementation of clinical guidelines Source: Eur Respir J 2005; 26: Suppl. 49, 258s Year: 2005 Immediate versus delayed admission to the intensive care unit for severe community-acquired pneumonia Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia Year: 2009 Studying the association between mortality in patients requiring hospital admission for Community Acquired Pneumonia and pre-hospital antibiotic treatment in primary care Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis   Year: 2017 Incidence and mortality of pneumonia in intensive care unit patients Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU Year: 2003 Mortality and cost analysis of community acquired pneumonia cases requiring intensive care unit follow up according to seasons Source: Annual Congress 2011 - Intensive care outcome Year: 2011 Consequences of community acquired pneumonia requiring admission to hospital in childhood Source: Eur Respir J 2004; 24: Suppl. 48, 171s Year: 2004 Incidence, etiology and prevention strategies in early and late onset ventilator associated pneumonia in a tertiary care intensive care unit Source: Annual Congress 2012 - Respiratory infections: prognosis and outcome Year: 2012 Health care associated pneumonia versus community acquired pneumonia: Comparison of etiology, treatment and prognosis Source: Annual Congress 2012 - Viral infections and rare respiratory infections Year: 2012 The impact of a delay in intensive care unit admission for community-acquired pneumonia Source: Eur Respir J 2010; 36: 826-833 Year: 2010 Elderly patients admitted with pneumonia in the intensive care unit: clinical characteristics and predictors of survival Source: Annual Congress 2009 - Complications of respiratory infections: impact of comorbidities and infections caused by Aspergillus Year: 2009 Prognosis factors influencing three-month respiratory outcomes in intensive care unit survivors after COVID-19 pneumonia Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure Year: 2021 Model of diagnosis scoring, clinical and molecular profile of invasive pulmonary aspergillosis (IPA) in ICU patients Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015